betamethasone-17,21-dipropionate has been researched along with Alopecia Areata in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Albalat, W; Elradi, M; Nassar, A; Radwan, M | 1 |
| Balevi, A; Özdemir, M; Ustuner, P | 1 |
| Balducci, A; Casadio, C; Farina, P; Mancuso, G; Milani, M; Staffa, M; Valenti, L | 1 |
3 trial(s) available for betamethasone-17,21-dipropionate and Alopecia Areata
| Article | Year |
|---|---|
Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study.
Topics: Adult; Alopecia Areata; Child; Clobetasol; Humans; Tacrolimus; Treatment Outcome; Vitamin D | 2023 |
Best dilution of the best corticosteroid for intralesional injection in the treatment of localized alopecia areata in adults.
Topics: Adolescent; Adult; Alopecia Areata; Betamethasone; Dermoscopy; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Young Adult | 2017 |
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial.
Topics: Administration, Topical; Adult; Alopecia Areata; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Dosage Forms; Female; Humans; Male; Middle Aged; Prospective Studies; Single-Blind Method; Treatment Outcome | 2003 |